share

Ethyl-6,7-Difluoro-1,4-Dihydro-4-Oxo-3-Xynoline Carbonate CAS NO 121873-01-6


Unit Price:

CAS No.:121873-01-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Ethyl-6,7-Difluoro-1,4-Dihydro-4-Oxo-3-Xynoline Carbonate is a high-purity, advanced pharmaceutical intermediate characterized by its specific fluorinated quinolone core structure. This compound is critical for the synthesis of novel, potent antibacterial agents, offering researchers and manufacturers a reliable building block for complex molecular development. It is primarily required by pharmaceutical R&D laboratories and active pharmaceutical ingredient (API) producers focused on next-generation fluoroquinolone antibiotics.

Application

  • Pharmaceutical Intermediate: Serves as a key synthetic precursor in the production of new-generation fluoroquinolone antibiotic APIs.
  • Antibacterial Drug Research: Used in medicinal chemistry for the design, synthesis, and structure-activity relationship (SAR) studies of novel antibacterial compounds.
  • Process Chemistry Development: Employed in scaling up and optimizing synthetic routes for antibiotic manufacturing under cGMP conditions.
  • Reference Standard: Utilized as an analytical standard for quality control and impurity profiling in API production.
  • Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) specializing in high-potency active pharmaceutical ingredients.

Basic Information

Product Name Ethyl-6,7-Difluoro-1,4-Dihydro-4-Oxo-3-Xynoline Carbonate
CAS No. 121873-01-6
Molecular Formula C₁₃H₉F₂NO₄
Molecular Weight 281.21 g/mol
Synonyms Ethyl 6,7-Difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate; 3-Quinolinecarboxylic acid, 6,7-difluoro-1,4-dihydro-4-oxo-, ethyl ester; 6,7-Difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester; Ethyl 6,7-Difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate; 121873-01-6; Difluoroquinolone Ester Intermediate
EINECS Contact for details

Quality Control

Our Ethyl-6,7-Difluoro-1,4-Dihydro-4-Oxo-3-Xynoline Carbonate is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for pharmaceutical synthesis. Production adheres to in-house specifications aligned with ICH guidelines. A comprehensive Certificate of Analysis (COA) detailing identity, purity (typically >98% by HPLC), and impurity profiles is provided with each shipment to support your regulatory and R&D requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from strong oxidizing agents and strong bases. For long-term storage, consider under an inert atmosphere to maintain stability.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Residual Solvents (GC) Complies with ICH Q3C guidelines
Loss on Drying ≤ 0.5%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.